Basic Information
| LncRNA/CircRNA Name | DDX11-AS1 |
| Synonyms | NA |
| Region | GRCh38_12:31020763-31073847 |
| Ensemble | ENSG00000245614 |
| Refseq | NR_038927 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | RT-qPCR, Western blot |
| Sample | osteosarcoma cell lines (SaOS2, MG63, HOS and U2OS) |
| Expression Pattern | up-regulated |
| Function Description | DDX11 overexpression could reversed the DDX11-AS1 downregulation-mediated effect on osteosarcoma progression. |
| Pubmed ID | 32014424 |
| Year | 2020 |
| Title | DDX11-AS1 contributes to osteosarcoma progression via stabilizing DDX11 |
External Links
| Links for DDX11-AS1 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |